<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1665-1146</journal-id>
<journal-title><![CDATA[Boletín médico del Hospital Infantil de México]]></journal-title>
<abbrev-journal-title><![CDATA[Bol. Med. Hosp. Infant. Mex.]]></abbrev-journal-title>
<issn>1665-1146</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Salud, Hospital Infantil de México Federico Gómez]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1665-11462006000600005</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Foramen oval persistente en pacientes pediátricos con migraña]]></article-title>
<article-title xml:lang="en"><![CDATA[Patent foramen ovale in pediatric patients with migraine]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Urrutia-Torres]]></surname>
<given-names><![CDATA[Francisco]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Barragán-Pérez]]></surname>
<given-names><![CDATA[Eduardo]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Espinosa-Islas]]></surname>
<given-names><![CDATA[Gonzalo]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pierdant]]></surname>
<given-names><![CDATA[Mauricio]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Hernández]]></surname>
<given-names><![CDATA[Marisela]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Capistro-Hurtado]]></surname>
<given-names><![CDATA[Fernando]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Huerta-Huerta]]></surname>
<given-names><![CDATA[Alma]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guerra-Molina]]></surname>
<given-names><![CDATA[Diana]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santana-García]]></surname>
<given-names><![CDATA[Feliciano]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Espinoza-Monteros]]></surname>
<given-names><![CDATA[Rubén]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Aguilar]]></surname>
<given-names><![CDATA[Juan]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Garza-Morales]]></surname>
<given-names><![CDATA[Saúl]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A02">
<institution><![CDATA[,Hospital Infantil de México Federico Gómez Departamento de Cardiología ]]></institution>
<addr-line><![CDATA[México D. F]]></addr-line>
</aff>
<aff id="A03">
<institution><![CDATA[,Hospital Infantil de San Luis Potosí Departamento de Cardiología ]]></institution>
<addr-line><![CDATA[México ]]></addr-line>
</aff>
<aff id="A01">
<institution><![CDATA[,Hospital Infantil de México Federico Gómez Departamento de Neurología ]]></institution>
<addr-line><![CDATA[México D.F.]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2006</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2006</year>
</pub-date>
<volume>63</volume>
<numero>6</numero>
<fpage>389</fpage>
<lpage>394</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1665-11462006000600005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1665-11462006000600005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1665-11462006000600005&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Introducción. Objetivo: determinar la prevalencia del foramen oval permeable en pacientes pediátricos con migraña. Material y métodos. Pacientes pediátricos atendidos en la Consulta Externa del Servicio de Neurología del Hospital Infantil de México Federico Gómez, de ambos sexos, conocidos con diagnóstico de migraña (con o sin aura) según los criterios de la Sociedad Internacional de Cefalea, en el período comprendido entre noviembre de 2005 y junio de 2006. Posterior a la identificación del tipo de migraña, se realizó un estudio de ecocardiografía bidimensional Doppler color en búsqueda de la persistencia de foramen oval. Resultados. Se estudiaron 40 pacientes, 57% de sexo femenino; con un límite de 5 a 17 años de edad; 42% (n =17) tuvieron diagnóstico de migraña con aura y el resto migraña sin aura. De acuerdo al tiempo de evolución de la enfermedad, 35.5% de los menores tenía 1 año, 25%, 2 años, 17%, 3 años y sólo 7%, 5 años. No se encontró asociación estadísticamente significativa entre el sexo del paciente y algún tipo de migraña. El foramen oval permeable se presentó en 10 pacientes, 5 fueron varones. Hubo persistencia del foramen oval en 8 pacientes con migraña y aura, y en 2 pacientes con migraña sin aura. Conclusión. Dado que la persistencia del foramen oval en pacientes adultos con migraña se ha asociado a eventos vasculares, es de suma importancia detectar esta anomalía en niños con este diagnóstico para evitar complicaciones secundarias en forma temprana. Para comprobar la hipótesis de que la persistencia del foramen oval contribuye a los ataques de migraña, se debe realizar un estudio prospectivo que investigue los efectos del cierre del foramen oval en la frecuencia de los ataques de migraña.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Introduction. Because the patency of foramen ovale in adult patients with migraine has been detected to have association with vascular events, we think it is of great importance to detect this cardiovascular anomaly in children with the diagnosis of migraine and prevent secondary complications. Objective: Determine the prevalence of patent foramen ovale in pediatric patients with migraine. Material and methods. Children diagnosed with migraine (with or without aura) according to the criteria of the International Headache Society seen during the period between November 2005 and June 2006 in the Department of Pediatric Neurology at the Hospital Infantil de Mexico Federico Gomez were enrolled and a bidimensional Doppler echocardiogram was performed looking for the persistence of foramen ovale. Results. We included 40 patients with ages ranging between 5 to 17 years, 57% were girls and 42% presented migraine with aura. Based on the time of evolution our study group was stratified as follows: 16% less than a year, 35% 1 year, 25% 2 years, 17% 3 years and 7% 5 years. We found no association between gender and a specific type of migraine. We found patency of foramen ovale in 11 patients (27.5%), 5 females and 6 males; 9 (81.8%) patients presented migraine with aura and 2 (18.1%) without aura. Conclusion. We found a high prevalence of patent foramen ovale in patients with migraine with aura. From 17 patients in our study group with diagnosis of migraine with aura; 9 of them (52%) had ultrasonographic finding of patency of the foramen.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Cefalea migrañosa]]></kwd>
<kwd lng="es"><![CDATA[migraña con aura]]></kwd>
<kwd lng="es"><![CDATA[persistencia del foramen oval]]></kwd>
<kwd lng="en"><![CDATA[Migraine]]></kwd>
<kwd lng="en"><![CDATA[migraine with aura]]></kwd>
<kwd lng="en"><![CDATA[patency of foramen ovale]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="justify"><font face="verdana" size="4">Art&iacute;culo original</font></p>     <p align="justify"><font face="verdana" size="2">&nbsp;</font></p>     <p align="center"><font face="verdana" size="4"><b>Foramen oval persistente en pacientes pedi&aacute;tricos con migra&ntilde;a</b></font></p>     <p align="center"><font face="verdana" size="2">&nbsp;</font></p>     <p align="center"><font face="verdana" size="3"><b>Patent foramen ovale in pediatric patients with migraine</b></font></p>     <p align="center"><font face="verdana" size="2">&nbsp;</font></p>     <p align="center"><font face="verdana" size="2"><b>Dr. Francisco Urrutia&#150;Torres<sup>1</sup>, Dr. Eduardo Barrag&aacute;n&#150;P&eacute;rez<sup>1</sup>, Dr. Gonzalo Espinosa&#150;Islas<sup>2</sup>, Dr. Mauricio Pierdant<sup>3</sup>, Dra. Marisela Hern&aacute;ndez&#150;Hern&aacute;ndez<sup>1</sup>, Dr. Fernando Capistro&#150;Hurtado<sup>1</sup>, Dra. Alma Huerta&#150;Huerta<sup>1</sup>, Dra. Diana Guerra&#150;Molina<sup>1</sup>, Dr. Feliciano Santana&#150;Garc&iacute;a<sup>1</sup>, Dr. Rub&eacute;n Espinoza&#150;Monteros<sup>1</sup>, Dr. Juan Hern&aacute;ndez&#150;Aguilar<sup>1</sup>, Dr. Sa&uacute;l Garza&#150;Morales<sup>1</sup></b></font></p>     <p align="center"><font face="verdana" size="2">&nbsp;</font></p>     <p align="justify"><font face="verdana" size="2"><i>1 Departamento de Neurolog&iacute;a</i></font></p>     <p align="justify"><font face="verdana" size="2"><i>2 Departamento de Cardiolog&iacute;a, Hospital Infantil de M&eacute;xico Federico G&oacute;mez, M&eacute;xico, D. F.</i></font></p>     ]]></body>
<body><![CDATA[<p align="justify"><font face="verdana" size="2"><i>3 Departamento de Cardiolog&iacute;a, Hospital Infantil de San Luis Potos&iacute;, M&eacute;xico</i></font></p>     <p align="justify"><font face="verdana" size="2">&nbsp;</font></p>     <p align="justify"><font face="verdana" size="2"><b>Solicitud de sobretiros:</b>    <br>   Dr. Eduardo Barrag&aacute;n P&eacute;rez    <br>   Departamento de Neurolog&iacute;a, Hospital Infantil de M&eacute;xico Federico G&oacute;mez    <br>   Calle Dr. M&aacute;rquez No. 162, Col. Doctores, Deleg. Cuauhtemoc    <br>   C.P. 06720, M&eacute;xico, D.F., M&eacute;xico</font></p>     <p align="justify"><font face="verdana" size="2">&nbsp;</font></p>     <p align="justify"><font face="verdana" size="2"> Fecha de recepci&oacute;n: 22&#150;11&#150;2006.    <br> Fecha de aprobaci&oacute;n: 02&#150;02&#150;2007.</font></p>     ]]></body>
<body><![CDATA[<p align="justify"><font face="verdana" size="2">&nbsp;</font></p>     <p align="justify"><font face="verdana" size="2"><b>Resumen</b></font></p>     <p align="justify"><font face="verdana" size="2"><i>Introducci&oacute;n. </i>Objetivo: determinar la prevalencia del foramen oval permeable en pacientes pedi&aacute;tricos con migra&ntilde;a.</font></p>     <p align="justify"><font face="verdana" size="2"><i>Material y m&eacute;todos. </i>Pacientes pedi&aacute;tricos atendidos en la Consulta Externa del Servicio de Neurolog&iacute;a del Hospital Infantil de M&eacute;xico Federico G&oacute;mez, de ambos sexos, conocidos con diagn&oacute;stico de migra&ntilde;a (con o sin aura) seg&uacute;n los criterios de la Sociedad Internacional de Cefalea, en el per&iacute;odo comprendido entre noviembre de 2005 y junio de 2006. Posterior a la identificaci&oacute;n del tipo de migra&ntilde;a, se realiz&oacute; un estudio de ecocardiograf&iacute;a bidimensional Doppler color en b&uacute;squeda de la persistencia de foramen oval.</font></p>     <p align="justify"><font face="verdana" size="2"><i>Resultados. </i>Se estudiaron 40 pacientes, 57% de sexo femenino; con un l&iacute;mite de 5 a 17 a&ntilde;os de edad; 42% (n =17) tuvieron diagn&oacute;stico de migra&ntilde;a con aura y el resto migra&ntilde;a sin aura. De acuerdo al tiempo de evoluci&oacute;n de la enfermedad, 35.5% de los menores ten&iacute;a 1 a&ntilde;o, 25%, 2 a&ntilde;os, 17%, 3 a&ntilde;os y s&oacute;lo 7%, 5 a&ntilde;os. No se encontr&oacute; asociaci&oacute;n estad&iacute;sticamente significativa entre el sexo del paciente y alg&uacute;n tipo de migra&ntilde;a. El foramen oval permeable se present&oacute; en 10 pacientes, 5 fueron varones. Hubo persistencia del foramen oval en 8 pacientes con migra&ntilde;a y aura, y en 2 pacientes con migra&ntilde;a sin aura.</font></p>     <p align="justify"><font face="verdana" size="2"><i>Conclusi&oacute;n. </i>Dado que la persistencia del foramen oval en pacientes adultos con migra&ntilde;a se ha asociado a eventos vasculares, es de suma importancia detectar esta anomal&iacute;a en ni&ntilde;os con este diagn&oacute;stico para evitar complicaciones secundarias en forma temprana. Para comprobar la hip&oacute;tesis de que la persistencia del foramen oval contribuye a los ataques de migra&ntilde;a, se debe realizar un estudio prospectivo que investigue los efectos del cierre del foramen oval en la frecuencia de los ataques de migra&ntilde;a.</font></p>     <p align="justify"><font face="verdana" size="2"><b>Palabras clave. </b>Cefalea migra&ntilde;osa; migra&ntilde;a con aura; persistencia del foramen oval.</font></p>     <p align="justify"><font face="verdana" size="2">&nbsp;</font></p>     <p align="justify"><font face="verdana" size="2"><b>Abstract</b></font></p>     <p align="justify"><font face="verdana" size="2"><i>Introduction. </i>Because the patency of foramen ovale in adult patients with migraine has been detected to have association with vascular events, we think it is of great importance to detect this cardiovascular anomaly in children with the diagnosis of migraine and prevent secondary complications. Objective: Determine the prevalence of patent foramen ovale in pediatric patients with migraine.</font></p>     ]]></body>
<body><![CDATA[<p align="justify"><font face="verdana" size="2"><i>Material and methods. </i>Children diagnosed with migraine (with or without aura) according to the criteria of the International Headache Society seen during the period between November 2005 and June 2006 in the Department of Pediatric Neurology at the Hospital Infantil de Mexico Federico Gomez were enrolled and a bidimensional Doppler echocardiogram was performed looking for the persistence of foramen ovale.</font></p>     <p align="justify"><font face="verdana" size="2"><i>Results. </i>We included 40 patients with ages ranging between 5 to 17 years, 57% were girls and 42% presented migraine with aura. Based on the time of evolution our study group was stratified as follows: 16% less than a year, 35% 1 year, 25% 2 years, 17% 3 years and 7% 5 years. We found no association between gender and a specific type of migraine. We found patency of foramen ovale in 11 patients (27.5%), 5 females and 6 males; 9 (81.8%) patients presented migraine with aura and 2 (18.1%) without aura.</font></p>     <p align="justify"><font face="verdana" size="2"><i>Conclusion. </i>We found a high prevalence of patent foramen ovale in patients with migraine with aura. From 17 patients in our study group with diagnosis of migraine with aura; 9 of them (52%) had ultrasonographic finding of patency of the foramen.</font></p>     <p align="justify"><font face="verdana" size="2"><b>Key words. </b>Migraine; migraine with aura; patency of foramen ovale.</font></p>     <p align="justify"><font face="verdana" size="2">&nbsp;</font></p>     <p align="justify"><font face="verdana" size="2"><b>Introducci&oacute;n</b></font></p>     <p align="justify"><font face="verdana" size="2">La migra&ntilde;a es un trastorno com&uacute;n caracterizado por episodios de cefalea grave recurrente y una gran variedad de fen&oacute;menos y s&iacute;ntomas neurol&oacute;gicos. En el paciente pedi&aacute;trico es la segunda causa en prevalencia entre las cefaleas primarias, despu&eacute;s de las cefaleas de tipo tensional. La migra&ntilde;a se divide en dos subtipos: migra&ntilde;a sin aura, la cual es un s&iacute;ndrome caracterizado por cefalea con s&iacute;ntomas espec&iacute;ficos asociados, y migra&ntilde;a con aura, caracterizada principalmente por s&iacute;ntomas neurol&oacute;gicos focales que usualmente preceden o algunas veces acompa&ntilde;an a la cefalea.<sup>1</sup> El conocimiento actual de la fisiopatolog&iacute;a de la migra&ntilde;a apoya la existencia de un sistema anat&oacute;mico y funcional que desencadena la capacidad de desarrollar crisis migra&ntilde;osa en individuos susceptibles. Se estima que la migra&ntilde;a con aura afecta a 6.6 por 1 000 personas&#150;a&ntilde;o, y sin aura, de 10 por 1 000 personas&#150;a&ntilde;o, entre los 10 y 11 a&ntilde;os de edad.<sup>2 </sup>En las mujeres la incidencia de migra&ntilde;a con aura es m&aacute;xima entre los 13 y 14 a&ntilde;os, con 14.1 por 1 000 personas&#150;a&ntilde;o, y de la migra&ntilde;a sin aura entre los 14 y 17 a&ntilde;os, con una incidencia de 18.9 por 1 000 personas&#150;a&ntilde;o. La prevalencia a los siete a&ntilde;os es de 1.2 a 3.2% y de los 7 a 15 a&ntilde;os es de 4 a 11%.<sup>3</sup> En general, en la infancia la prevalencia de migra&ntilde;a se incrementa con la edad.<sup>4</sup> La migra&ntilde;a es un trastorno multifactorial polig&eacute;nico donde concurren factores gen&eacute;ticamente determinados y ambientales. A pesar de los diversos estudios realizados en las &uacute;ltimas d&eacute;cadas, la etiolog&iacute;a, la patog&eacute;nesis y la evoluci&oacute;n de la migra&ntilde;a son a&uacute;n inciertas.<sup>5,6</sup> Se ha descrito la asociaci&oacute;n migra&ntilde;a&#150;infarto, riesgo asociado con la alta incidencia de foramen oval persistente (FOP) en la poblaci&oacute;n de pacientes con <i>stroke,</i><sup>7,8</sup> esto ha llevado a especular que el FOP pueda jugar un papel en la patog&eacute;nesis de la migra&ntilde;a.<sup>9</sup></font></p>     <p align="justify"><font face="verdana" size="2">Se sabe que la prevalencia de FOP es m&aacute;s frecuente en la poblaci&oacute;n que presenta migra&ntilde;a que en la poblaci&oacute;n general.<sup>10&#150;13</sup> Recientemente los estudios de ecocardiograma Doppler han mostrado alta prevalencia de comunicaci&oacute;n intracardiaca de derecha a izquierda en pacientes con migra&ntilde;a con aura (45 a 48%) comparado con controles (16 a 20%).<sup>14&#150;18 </sup>Algunos de estos estudios han reportado la prevalencia de FOP en pacientes con migra&ntilde;a con aura y sin aura. La mayor&iacute;a de estos estudios reportan tama&ntilde;os de muestras diferentes.</font></p>     <p align="justify"><font face="verdana" size="2">La correlaci&oacute;n entre el cierre del FOP y la disminuci&oacute;n de la gravedad y frecuencia de la migra&ntilde;a apoya m&uacute;ltiples teor&iacute;as de la patog&eacute;nesis de la migra&ntilde;a, incluyendo un papel causal de micro&eacute;mbolos parad&oacute;jicos en las ramas terminales de la arteria basovertebral.<sup>18</sup> Una comunicaci&oacute;n intracardiaca pudiera permitir la liberaci&oacute;n de sustancias vasoactivas como el p&eacute;ptido natriur&eacute;tico atrial, factores plaquetarios y aminas, los cuales podr&iacute;an actuar como factores end&oacute;genos disparadores de la migra&ntilde;a. En algunos estudios se demuestra el decremento de la intensidad y frecuencia de la migra&ntilde;a con aura, no as&iacute; de la migra&ntilde;a sin aura, posterior al cierre del FOP. Estos hallazgos pudieran explicarse por la teor&iacute;a de que la migra&ntilde;a sin aura es similar fisiol&oacute;gicamente a la migra&ntilde;a con aura, excepto que en esta &uacute;ltima la circulaci&oacute;n se afecta en la corteza, principalmente en &aacute;reas visuales, motoras y sensitivas. Si los micro&eacute;mbolos parad&oacute;jicos que se producen por la presencia del FOP son los responsables de la migra&ntilde;a con aura, entonces el cierre de esta comunicaci&oacute;n mejora la evoluci&oacute;n de la cefalea en tales pacientes. Hay informes de dos casos de pacientes con migra&ntilde;a a quienes se les realiz&oacute; cierre de una comunicaci&oacute;n intra&#150;atrial y que posterior al cierre mostraron incremento en la frecuencia de la cefalea migra&ntilde;osa.<sup>19&#150;22</sup> Sin embargo, en ambos casos se encontr&oacute; un defecto septal atrial relativamente grande. Wilmshurst y col.<sup>21</sup> reportan 11 pacientes a quienes se les realiz&oacute; cierre del FOP, de los cuales cuatro tuvieron per&iacute;odos frecuentes de migra&ntilde;a posterior al cierre.</font></p>     <p align="justify"><font face="verdana" size="2">Es posible que el FOP juegue un papel causal en la migra&ntilde;a de algunos pacientes, y que la insuficiente oxigenaci&oacute;n de la sangre en estos casos sea un disparador de los per&iacute;odos de cefalea.<sup>23&#150;27 </sup>En los ni&ntilde;os no se ha estudiado la asociaci&oacute;n entre FOP y migra&ntilde;a.</font></p>     ]]></body>
<body><![CDATA[<p align="justify"><font face="verdana" size="2">&nbsp;</font></p>     <p align="justify"><font face="verdana" size="2"><b>Material y m&eacute;todos</b></font></p>     <p align="justify"><font face="verdana" size="2">Se estudi&oacute; a todos los pacientes atendidos en la consulta externa del Servicio de Neurolog&iacute;a del Hospital Infantil de M&eacute;xico Federico G&oacute;mez, el cual es un hospital de atenci&oacute;n de servicio especializado de referencia pedi&aacute;trica. Todos los pacientes estudiados son casos de la cl&iacute;nica de cefalea y con diagn&oacute;stico de migra&ntilde;a (con o sin aura) seg&uacute;n los criterios de la Sociedad Internacional de Cefalea. Se trat&oacute; ni&ntilde;os de ambos sexos, con diagn&oacute;stico de cefalea migra&ntilde;osa, en el per&iacute;odo comprendido entre noviembre de 2005 y junio de 2006. Posterior a la identificaci&oacute;n del tipo de migra&ntilde;a, se procedi&oacute; a realizar un estudio de ecocardiograf&iacute;a bidimensional Doppler color, con un equipo sonus 5500 de Phillips, utilizando un transductor F8. Los estudios se realizaron en el Departamento de Cardiolog&iacute;a del Hospital Infantil de M&eacute;xico Federico G&oacute;mez por un cardi&oacute;logo pediatra experto en ecocardiograf&iacute;a infantil, quien ignoraba el tipo de cefalea que presentaban los pacientes. En tres casos en los que exist&iacute;a duda se utiliz&oacute; el medio de contraste con soluci&oacute;n para poder verificar el foramen oval por las burbujas que pasan a trav&eacute;s del mismo. Los pacientes se dividieron en dos grupos, aqu&eacute;llos con FOP y los que no presentaban esta malformaci&oacute;n. Posterior a la realizaci&oacute;n del ecocardiograma, se procedi&oacute; a seguir en la consulta externa la evoluci&oacute;n del paciente.</font></p>     <p align="justify"><font face="verdana" size="2">&nbsp;</font></p>     <p align="justify"><font face="verdana" size="2"><b>Resultados</b></font></p>     <p align="justify"><font face="verdana" size="2">Se estudiaron 40 casos, 23 (57%) del sexo femenino y 17 (43%) del masculino. La edad de los pacientes tuvo un l&iacute;mite de 5 a 17 a&ntilde;os, con una media de 11.65 y desviaci&oacute;n est&aacute;ndar (DE) de &plusmn; 3.14. Del total de los pacientes, 17 (43%) tuvieron diagn&oacute;stico de migra&ntilde;a con aura y 23 (57%) de migra&ntilde;a sin aura.</font></p>     <p align="justify"><font face="verdana" size="2">Con respecto al tiempo de evoluci&oacute;n de la enfermedad en a&ntilde;os, los datos se muestran en el <a href="#c1">cuadro 1</a>.</font></p>     <p align="center"><font face="verdana" size="2"><a name="c1"></a></font></p>     <p align="center"><font face="verdana" size="2"><img src="/img/revistas/bmim/v63n6/a5c1.jpg"></font></p>     <p align="justify"><font face="verdana" size="2">De los 17 pacientes de migra&ntilde;a con aura, cinco fueron del sexo masculino y 12 del femenino. De los 23 pacientes con migra&ntilde;a sin aura, 11 fueron del sexo femenino y 12 del masculino. No se encontr&oacute; asociaci&oacute;n estad&iacute;sticamente significativa entre el sexo del paciente y el diagn&oacute;stico: migra&ntilde;a con aura y migra&ntilde;a sin aura <a href="#c1">(Cuadro 1)</a>.</font></p>     ]]></body>
<body><![CDATA[<p align="justify"><font face="verdana" size="2">El FOP se encontr&oacute; en 11 pacientes (28% intervalo de confianza del 95% &#91;IC95%&#93; de 22 a 52%), seis fueron del sexo masculino y cinco del femenino. Se encontr&oacute; FOP en nueve pacientes con migra&ntilde;a con aura, y en dos pacientes con migra&ntilde;a sin aura (raz&oacute;n de momios 5.4 &#91;IC95% de 1.31 a 22.3%&#93;) (P &lt; 0.008) <a href="#c2">(Cuadro 2)</a>.</font></p>     <p align="center"><font face="verdana" size="2"><a name="c2"></a></font></p>     <p align="center"><font face="verdana" size="2"><img src="/img/revistas/bmim/v63n6/a5c2.jpg"></font></p>     <p align="justify"><font face="verdana" size="2">&nbsp;</font></p>     <p align="justify"><font face="verdana" size="2"><b>Discusi&oacute;n</b></font></p>     <p align="justify"><font face="verdana" size="2">Estos datos indican que, en un porcentaje significativo de pacientes, principalmente en aqu&eacute;llos con diagn&oacute;stico de migra&ntilde;a con aura (m&aacute;s de la mitad de la muestra de pacientes con este diagn&oacute;stico), hay asociaci&oacute;n con FOP, lo cual sugiere una participaci&oacute;n directa en la fisiopatolog&iacute;a de los ataques de migra&ntilde;a. Se sabe que la relaci&oacute;n entre estos dos diagn&oacute;sticos ya se ha reportado en adultos, inclusive con mayor tama&ntilde;o de los defectos, pero no se encontr&oacute; literatura que informe esta asociaci&oacute;n en ni&ntilde;os.</font></p>     <p align="justify"><font face="verdana" size="2">Igualmente, ante la relaci&oacute;n que se conoce entre el FOP y el desarrollo de evento vascular cerebral en adultos, parece de suma importancia ahondar un poco m&aacute;s en la investigaci&oacute;n en ni&ntilde;os, ya que pudiera ayudar a tomar medidas preventivas. A partir de &eacute;ste se realizar&aacute; otro de tipo prospectivo, para evaluar la repercusi&oacute;n en los s&iacute;ntomas migra&ntilde;osos al cierre del foramen oval.</font></p>     <p align="justify"><font face="verdana" size="2">En estos pacientes de este estudio diagnosticados con migra&ntilde;a, independientemente que sean con aura o sin ella, y aunque la muestra sea peque&ntilde;a, se encontr&oacute; una prevalencia de 25% de FOP, similar a la referida en pacientes adultos con migra&ntilde;a. Esta prevalencia de FOP en pacientes migra&ntilde;osos, es mayor a la reportada en pacientes sin migra&ntilde;a, que es alrededor de 10 a 12%.</font></p>     <p align="justify"><font face="verdana" size="2">Se sabe que en ni&ntilde;os predomina la migra&ntilde;a sin aura, pero dada la alta asociaci&oacute;n que se encontr&oacute; entre aquellos pacientes en los que se diagnostic&oacute; migra&ntilde;a con aura y la presencia de FOP, se consider&oacute; importante tratar de descartar este diagn&oacute;stico, y en aqu&eacute;llos en los que se confirme, dar un seguimiento adecuado para valorar posibles complicaciones y nuevas opciones de manejo.</font></p>     <p align="justify"><font face="verdana" size="2">Ciertamente, varios factores intervienen en la fisiopatolog&iacute;a de la migra&ntilde;a. Sin embargo, el tener en esta muestra de pacientes de migra&ntilde;a con aura a 53% con FOP, se&ntilde;ala que podr&iacute;a ser un factor importante en la producci&oacute;n de la misma.</font></p>     ]]></body>
<body><![CDATA[<p align="justify"><font face="verdana" size="2">Dado que el FOP en adultos con migra&ntilde;a se ha asociado a eventos vasculares, es de suma importancia detectar tal anomal&iacute;a en ni&ntilde;os con este diagn&oacute;stico y evitar complicaciones en forma temprana. Para comprobar la hip&oacute;tesis de que el FOP contribuye a los ataques de migra&ntilde;a, conviene realizar un estudio prospectivo que investigue los efectos del cierre del foramen oval en la frecuencia de los ataques de migra&ntilde;a.</font></p>     <p align="justify"><font face="verdana" size="2">&nbsp;</font></p>     <p align="justify"><font face="verdana" size="2"><b>Referencias</b></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">1. Headache Classification Committee of the International Headache Society. Classification and Diagnostic Criteria for Headache disorders, cranial neuralgias and facial pain. Cephalalgia. 2004; 24 Supl 1: 1&#150;160.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490432&pid=S1665-1146200600060000500001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">2. Maytal J, Young M, Shechter BA, Lipton RB. Pediatric migraine and the International Headache Society (IHS) criteria. Neurology. 1997; 48: 602.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490434&pid=S1665-1146200600060000500002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">3. Lipton RB, Bigal ME, Steiner TJ, Silberstein SD, Olsen J. The classification of the headaches. Neurology. 2004; 63: 427&#150;35.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490436&pid=S1665-1146200600060000500003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">4. Kenneth S, Sthepen A. Pediatric neurology: Principles &amp; practice. Fourth ed. Philadelphia: PA, Mosby; 2006. p. 747&#150;58.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490438&pid=S1665-1146200600060000500004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">5. Fenichel GM. Clinical Pediatric Neurology. A signs and symptoms approach. Fifth ed. Philadelphia: PA, Elsevier Saunders; 2005.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490440&pid=S1665-1146200600060000500005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">6. Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med. 2005; 118 Suppl 1: 3&#150;10S.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490442&pid=S1665-1146200600060000500006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">7. Welch KMA, D'Andrea G, Tepley N, Barkley GL. The concept of migraine as a state of central neuronal hyper&#150;excitability. Headache. 1990; 8: 817&#150;28.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490444&pid=S1665-1146200600060000500007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">8. Aurora SK, Ahmad BK, Welch KMA, Bhradhwaj P, Ramadan NM. Transcranial magnetic stimulation confirms hiperexcitability of occipital cortex in migraine. Neurology. 1998; 50: 1111&#150;4.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490446&pid=S1665-1146200600060000500008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">9. Lauritzen M. Pathophysiology of the migraine aura: The spreading depression theory. Brain. 1994; 117:199&#150;210.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490448&pid=S1665-1146200600060000500009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">10. Lauritzen M. Cortical spreading depression in migraine. Cephalalgia. 2001; 21: 757&#150;60.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490450&pid=S1665-1146200600060000500010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">11. Battelli L, Black KR, Wray SH. Transcranial magnetic stimulation of visual area V5 in migraine. Neurology. 2002; 58: 1066&#150;9.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490452&pid=S1665-1146200600060000500011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">12. Lears E, Rolf U. Neurobiology in primary headaches. Brain Res Rev. 2005; 48: 438&#150;56.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490454&pid=S1665-1146200600060000500012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">13. Stephen DS. Migraine. Lancet. 2004; 363: 381&#150;91.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490456&pid=S1665-1146200600060000500013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">14. Waeber C, Moskowitz MA. Therapeutic implications of central and peripheral neurologic mechanisms in migraine. Neurology. 2003; 61 Supl 4: 9&#150;S20.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490458&pid=S1665-1146200600060000500014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">15. Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology. 2005; 64 Supl 2: 9&#150;S15.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490460&pid=S1665-1146200600060000500015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">16. Tzourio C, Tehindrazanarivelo A, Iglesias S, Alperovitch A, Chedru FA. Case&#150;control study of migraine and risk of ischemic stroke in young women. BMJ. 1995; 310: 830&#150;3.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490462&pid=S1665-1146200600060000500016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">17. Del Sette M, Angeli S, Lenadri M, Ferreiro G, Bruzzone L, Finocchi C. Migraine with aura and right&#150;to&#150;left shunt on transcranial Doppler: a case&#150;control study. Cerebrovasc Dis. 1998; 8: 327&#150;30.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490464&pid=S1665-1146200600060000500017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">18. Anzola GP, Mangoni M, Guindani AC. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology. 1999; 52: 1622&#150;5.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490466&pid=S1665-1146200600060000500018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">19. Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right&#150;to&#150;left shunts. Clin Sci. 2001; 100: 215&#150;20.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490468&pid=S1665-1146200600060000500019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">20. Sztajzel R, Geround D, Roth S, Mermillod B, Le Floch R Jr. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis. 2002; 13: 102&#150;6.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490470&pid=S1665-1146200600060000500020&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">21. Wilmshurst P, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right&#150;to&#150;left shunts to prevent recurrence of decompression illness or stroke or for hemodynamic reasons. Lancet. 2000; 356: 1648&#150;51.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490472&pid=S1665-1146200600060000500021&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">22. Morandi E, Anzola GP, Angeli S, Castelli F, Onorato E. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Inter Cardiol. 2003; 16: 38&#150;42.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490474&pid=S1665-1146200600060000500022&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">23. Schwerzmann M, Wiher S, Nedeltchev K, Lagger M, Mattle B, Windecker D. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology. 2004; 62: 1399&#150;401.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490476&pid=S1665-1146200600060000500023&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">24. Yankovsky AE, Kuritzki A. Transformation into daily migraine with aura following transcutaneous atrial septal defect douse. Headache. 2003; 42: 496&#150;8.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490478&pid=S1665-1146200600060000500024&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">25. Schwerzmann M, Wiher S, Nedeltchev K, Meyer B, Seiler C. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology. 2005; 65: 1415&#150;8.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490480&pid=S1665-1146200600060000500025&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">26. Reisman M, Christofferson RD, Jerusum J, Olsen JV, Spencer M, Krabill K, et al. Migraine headache relief after trans&#150;catheter closure of patent foramen ovale. J Am College Cardiol. 2005; 45: 493&#150;5.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490482&pid=S1665-1146200600060000500026&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">27. Post MC, Thijs V, Herroelen L, Budts Wl. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology. 2004; 62: 1439&#150;40.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1490484&pid=S1665-1146200600060000500027&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<collab>Headache Classification Committee of the International Headache Society</collab>
<article-title xml:lang="en"><![CDATA[Classification and Diagnostic Criteria for Headache disorders, cranial neuralgias and facial pain]]></article-title>
<source><![CDATA[Cephalalgia]]></source>
<year>2004</year>
<numero>24^s1</numero>
<issue>24^s1</issue>
<supplement>1</supplement>
<page-range>1-160</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maytal]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Shechter]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Lipton]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Pediatric migraine and the International Headache Society (IHS) criteria]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>1997</year>
<numero>48</numero>
<issue>48</issue>
<page-range>602</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lipton]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
<name>
<surname><![CDATA[Bigal]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Steiner]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Silberstein]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Olsen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The classification of the headaches]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2004</year>
<numero>63</numero>
<issue>63</issue>
<page-range>427-35</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kenneth]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sthepen]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Pediatric neurology: Principles & practice]]></source>
<year>2006</year>
<edition>Fourth</edition>
<page-range>747-58</page-range><publisher-loc><![CDATA[Philadelphia^ePA PA]]></publisher-loc>
<publisher-name><![CDATA[Mosby]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fenichel]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
</person-group>
<source><![CDATA[Clinical Pediatric Neurology: A signs and symptoms approach]]></source>
<year>2005</year>
<edition>Fifth</edition>
<publisher-loc><![CDATA[Philadelphia^ePA PA]]></publisher-loc>
<publisher-name><![CDATA[Elsevier Saunders]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lipton]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
<name>
<surname><![CDATA[Bigal]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The epidemiology of migraine]]></article-title>
<source><![CDATA[Am J Med]]></source>
<year>2005</year>
<numero>118^s1</numero>
<issue>118^s1</issue>
<supplement>1</supplement>
<page-range>3-10S</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Welch]]></surname>
<given-names><![CDATA[KMA]]></given-names>
</name>
<name>
<surname><![CDATA[D'Andrea]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Tepley]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Barkley]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The concept of migraine as a state of central neuronal hyper-excitability]]></article-title>
<source><![CDATA[Headache]]></source>
<year>1990</year>
<numero>8</numero>
<issue>8</issue>
<page-range>817-28</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aurora]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmad]]></surname>
<given-names><![CDATA[BK]]></given-names>
</name>
<name>
<surname><![CDATA[Welch]]></surname>
<given-names><![CDATA[KMA]]></given-names>
</name>
<name>
<surname><![CDATA[Bhradhwaj]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ramadan]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Transcranial magnetic stimulation confirms hiperexcitability of occipital cortex in migraine]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>1998</year>
<numero>50</numero>
<issue>50</issue>
<page-range>1111-4</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lauritzen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Pathophysiology of the migraine aura: The spreading depression theory]]></article-title>
<source><![CDATA[Brain]]></source>
<year>1994</year>
<numero>117</numero>
<issue>117</issue>
<page-range>199-210</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lauritzen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cortical spreading depression in migraine]]></article-title>
<source><![CDATA[Cephalalgia]]></source>
<year>2001</year>
<numero>21</numero>
<issue>21</issue>
<page-range>757-60</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Battelli]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Black]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[Wray]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Transcranial magnetic stimulation of visual area V5 in migraine]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2002</year>
<numero>58</numero>
<issue>58</issue>
<page-range>1066-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lears]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rolf]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Neurobiology in primary headaches]]></article-title>
<source><![CDATA[Brain Res Rev]]></source>
<year>2005</year>
<numero>48</numero>
<issue>48</issue>
<page-range>438-56</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stephen]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Migraine]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2004</year>
<numero>363</numero>
<issue>363</issue>
<page-range>381-91</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Waeber]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Moskowitz]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Therapeutic implications of central and peripheral neurologic mechanisms in migraine]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2003</year>
<numero>61^s4</numero>
<issue>61^s4</issue>
<supplement>4</supplement>
<page-range>9-S20</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Waeber]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Moskowitz]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Migraine as an inflammatory disorder]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2005</year>
<numero>64^s2</numero>
<issue>64^s2</issue>
<supplement>2</supplement>
<page-range>9-S15</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tzourio]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Tehindrazanarivelo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Iglesias]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Alperovitch]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chedru]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Case-control study of migraine and risk of ischemic stroke in young women]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>1995</year>
<numero>310</numero>
<issue>310</issue>
<page-range>830-3</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Del Sette]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Angeli]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lenadri]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreiro]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Bruzzone]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Finocchi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study]]></article-title>
<source><![CDATA[Cerebrovasc Dis]]></source>
<year>1998</year>
<numero>8</numero>
<issue>8</issue>
<page-range>327-30</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anzola]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
<name>
<surname><![CDATA[Mangoni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Guindani]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>1999</year>
<numero>52</numero>
<issue>52</issue>
<page-range>1622-5</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wilmshurst]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Nightingale]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Relationship between migraine and cardiac and pulmonary right-to-left shunts]]></article-title>
<source><![CDATA[Clin Sci]]></source>
<year>2001</year>
<numero>100</numero>
<issue>100</issue>
<page-range>215-20</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sztajzel]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Geround]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Roth]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mermillod]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Le Floch]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke]]></article-title>
<source><![CDATA[Cerebrovasc Dis]]></source>
<year>2002</year>
<numero>13</numero>
<issue>13</issue>
<page-range>102-6</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wilmshurst]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Nightingale]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[KP]]></given-names>
</name>
<name>
<surname><![CDATA[Morrison]]></surname>
<given-names><![CDATA[WL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for hemodynamic reasons]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2000</year>
<numero>356</numero>
<issue>356</issue>
<page-range>1648-51</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morandi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Anzola]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
<name>
<surname><![CDATA[Angeli]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Castelli]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Onorato]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Transcatheter closure of patent foramen ovale: a new migraine treatment?]]></article-title>
<source><![CDATA[J Inter Cardiol]]></source>
<year>2003</year>
<numero>16</numero>
<issue>16</issue>
<page-range>38-42</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schwerzmann]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wiher]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Nedeltchev]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Lagger]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mattle]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Windecker]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2004</year>
<numero>62</numero>
<issue>62</issue>
<page-range>1399-401</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yankovsky]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Kuritzki]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Transformation into daily migraine with aura following transcutaneous atrial septal defect douse]]></article-title>
<source><![CDATA[Headache]]></source>
<year>2003</year>
<numero>42</numero>
<issue>42</issue>
<page-range>496-8</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schwerzmann]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wiher]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Nedeltchev]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Meyer]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Seiler]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Prevalence and size of directly detected patent foramen ovale in migraine with aura]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2005</year>
<numero>65</numero>
<issue>65</issue>
<page-range>1415-8</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reisman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Christofferson]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[Jerusum]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Olsen]]></surname>
<given-names><![CDATA[JV]]></given-names>
</name>
<name>
<surname><![CDATA[Spencer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Krabill]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Migraine headache relief after trans-catheter closure of patent foramen ovale]]></article-title>
<source><![CDATA[J Am College Cardiol]]></source>
<year>2005</year>
<numero>45</numero>
<issue>45</issue>
<page-range>493-5</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Post]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Thijs]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Herroelen]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Budts]]></surname>
<given-names><![CDATA[Wl]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2004</year>
<numero>62</numero>
<issue>62</issue>
<page-range>1439-40</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
